Mirum Pharmaceuticals to Present Data at Upcoming Medical Congresses
– 28-week data from Phase 2b VANTAGE PBC study highlighting improvements in itch and fatigue will be presented at EASL – Data from Mirum studies presented... Read more.
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Anthem Blue Cross/Blue Shield
DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable... Read more.
Plastec Technologies Reports Fiscal 2024 Financial Results
HONG KONG–(BUSINESS WIRE)–Plastec Technologies, Ltd. (OTCBB: PLTYF) (the “Company”) today reported audited financial results for the fiscal year... Read more.
Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics
Enhanced platform technology and the addition of a robust, high-quality CHO K-1 cell line decreases lead time to Investigational New Drug (IND) WALTHAM, Mass.–(BUSINESS... Read more.
Ankyra Therapeutics Announces Phase 1 Clinical Data at the 2025 AACR Annual Meeting and the first patient has been dosed with tolododekin alfa and cemiplimab
Ankyra Therapeutics announced preliminary clinical data today from Part 1 of their Phase 1 ANCHOR study evaluating an anchored IL-12 drug conjugate, tolododekin... Read more.
The Cheesecake Factory Celebrates Mom With Special Online Gift Card Offer
Receive a $10 Bonus Card for every $50 in Gift Cards Purchased Online Now through Mother’s Day CALABASAS HILLS, Calif.–(BUSINESS WIRE)–The Cheesecake... Read more.
Industrial Boiler Market Report 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Industrial Boiler Market by Fuel (Natural Gas, Coal, Oil), Boiler Type (Fire Tube, Water Tube), Function (Hot Water,... Read more.
Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer
Powered by Guardant Infinity smart liquid biopsy platform, advanced multiomic test evaluates genomic, epigenomic and RNA-based molecular data First tissue comprehensive... Read more.
Flashpoint Unveils New AI-Powered Risk Discovery, Curated Threat Feeds, and On-Demand Data Source Expansion at RSA Conference 2025
Newest advancements to Flashpoint Ignite make industry-leading threat data and intelligence more accessible so teams can extract more value and take action faster.... Read more.
NEUPATH HEALTH TO PRESENT AT THE 2025 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE
TORONTO–(BUSINESS WIRE)–NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering... Read more.